BMO cuts DXC Technology stock price target on revenue miss

BMO Capital cut DXC Technology’s price target to $10 from $17 while keeping a Market Perform rating, citing a revenue miss in GIS and fiscal 2027 guidance that came in below expectations on both revenue and EBIT margins. DXC also reported Q4 fiscal 2026 EPS of $0.77 versus $0.70 expected, but revenue missed at $3.13 billion versus $3.15 billion consensus. The stock trades at $8.91, near its 52-week low of $8.40, after an 18% drop over the past week.

Analysis

DXC is in the classic late-cycle turnaround trap: the equity is cheap only if management can stabilize the revenue base before margin compression overwhelms any cost actions. The near-term problem is not valuation, it is duration mismatch — the market is discounting that discretionary IT spend stays weak long enough to erode backlog quality and force further guidance resets. That creates a self-reinforcing loop where customers defer projects because the vendor looks structurally impaired, not just temporarily cyclical.

The second-order winner is less likely a direct peer and more likely larger IT services platforms with stronger balance sheets and broader cloud/cyber mix, which can absorb enterprise wallet share as buyers consolidate vendors. Any deceleration in DXC’s shorter-term project business should disproportionately benefit incumbents with sticky managed services and consulting attach rates, because procurement teams will favor execution certainty over price. That means the revenue leakage risk is not just share loss, but a mix shift toward lower-margin, lower-growth work that keeps reported growth depressed even if bookings stabilize.

The catalyst window is months, not days: a clean execution fix would need to show up in the next 1-2 quarters via guidance credibility and sequential margin stabilization. Until then, the stock remains exposed to another leg down if the market concludes fiscal 2027 is not a trough but a waypoint. The contrarian case is that expectations may already be close to punitive enough for a tactical bounce, but the ceiling is capped until management proves it can stop the negative revision cycle.

Key Decisions for Investors

• Maintain/enter a tactical short DXC for 1-3 months with a tight stop above the prior rebound zone; risk/reward favors another 10-20% downside if guidance credibility erodes further.
• Use put spreads rather than outright short stock on DXC into the next earnings/guidance window; aim for defined downside capture while limiting squeeze risk if management sounds more constructive.
• Pair long ACN or IBM vs short DXC over 2-4 quarters to express a quality-vs-turnaround trade; the thesis is that enterprise IT spend migrates toward scaled vendors with stronger execution.
• If you need a contrarian long, wait for capitulation and only buy on evidence of sequential revenue stabilization; otherwise the stock is a value trap rather than a mean-reversion setup.